An Open-label Study to Characterize the Pharmacokinetics and Safety of Oxycodone Hydrochloride q12h Controlled-Release (ORF) Tablets in Pediatric Patients Aged 6 to 16 Years Inclusive, Who Require Opioid Analgesia.

Trial Profile

An Open-label Study to Characterize the Pharmacokinetics and Safety of Oxycodone Hydrochloride q12h Controlled-Release (ORF) Tablets in Pediatric Patients Aged 6 to 16 Years Inclusive, Who Require Opioid Analgesia.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Aug 2012

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Acute pain
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 22 Mar 2012 Additional trial location added as reported by European Clinical Trials Database.
    • 22 Mar 2012 This trial is not authorised in United Kingdom.
    • 14 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top